DermaSensor™ quickly assesses information below the skin surface to give physicians more information in their decision-making.


DermaSensor™ is designed to improve early detection of skin cancer by helping clinicians to refer or biopsy skin cancer earlier and DermaSensor may also reduce the number of unnecessary referrals and biopsies.


Patients are expected to view DermaSensor™ as a supplemental and valuable addition to the skincare they already receive.


The non-invasive nature of DermaSensor™ is expected to be unintimidating to patients and reassure them that they are receiving high-quality care.


The machine-learning algorithm is derived from thousands of spectral samples of pathologically-verified lesions and is trained by expert data scientists.